Enveric Biosciences, Inc. Profile Avatar - Palmy Investing

Enveric Biosciences, Inc.

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related di…

Biotechnology
US, Naples [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Enveric Biosciences, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of ENVB's Analysis
CIK: 890821 CUSIP: 29405E208 ISIN: US29405E2081 LEI: - UEI: -
Secondary Listings
ENVB has no secondary listings inside our databases.